January 25, 2021
Dusan Kosijer apppointed CEO of Minaris Regenerative Medicine GmbH
MUNICH, Germany – January 25, 2021- Minaris Regenerative Medicine GmbH, a leading contract development and manufacturing organization (CDMO) for the cell and gene therapy industry fully owned by Showa Denko Materials Co., Ltd., announces the appointment of Dusan Kosijer as CEO of the European operations of Minaris as of January 1, 2021. Dusan Kosijer has served as Chief Financial Officer of ...
